BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13781051)

  • 1. [The "elevation of kaliemia-azotemia-oliguria" syndrome in ascitic cirrhosis. Mechanism and therapeutic results (failure of spirolactones)].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1013-21. PubMed ID: 13781051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of 30 cases of ascitic cirrhosis with spirolactone. Clinical and biological studies].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():997-1005. PubMed ID: 13781052
    [No Abstract]   [Full Text] [Related]  

  • 3. Isotope studies of the development of water and electrolyte disorders and azotemia during the treatment of ascites.
    CLOWDUS BF; SUMMERSKILL WH; CASEY TH; HIGGINS JA; ORVIS AL
    Gastroenterology; 1961 Oct; 41():360-70. PubMed ID: 13880005
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible hyponatremia and azotemia in a patient with cirrhosis and ascites.
    GALAMBOS JT; WILKINSON HA
    Am J Dig Dis; 1962 Jul; 7():642-7. PubMed ID: 13896294
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of the diuretic actions of delta-cortisone and spirolactone in the treatment of cirrhotic edema].
    VESIN P; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1005-12. PubMed ID: 13781048
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP; MARCHAL C; ANTOINE ; SAPELIER P; KIFFER B
    Rev Med Nancy; 1961; 86():801-20. PubMed ID: 13901929
    [No Abstract]   [Full Text] [Related]  

  • 7. THE KIDNEY IN CIRRHOSIS. I. CLINICAL AND BIOCHEMICAL FEATURES OF AZOTEMIA IN HEPATIC FAILURE.
    BALDUS WP; FEICHTER RN; SUMMERSKILL WH
    Ann Intern Med; 1964 Mar; 60():353-65. PubMed ID: 14128217
    [No Abstract]   [Full Text] [Related]  

  • 8. Urineserum urea nitrogen ratio; simple test of renal function in acute azotemia and oliguria.
    PERLMUTTER M; GROSSMAN SL; ROTHENBERG S; DOBKIN G
    J Am Med Assoc; 1959 Jul; 170(13):1533-7. PubMed ID: 13664557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyponatremia and hyperkalemia in an ascitic cirrhosis patient. Regression of these abnormalities after a digestive hemorrhage].
    VESIN P; VEYNE S; HIRSCH-MARIE H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1962 Jan 2-Feb 26; 113():123-8. PubMed ID: 13925633
    [No Abstract]   [Full Text] [Related]  

  • 10. [Respective indications of corticoids, hydrochlorothiazide and spirolactones in cirrhotic edema].
    VESIN P; CATTAN R
    Rev Med Suisse Romande; 1960 May; 80():338-41. PubMed ID: 13841979
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
    Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
    Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A
    Minerva Med; 1962 Jun; 53():1990-4. PubMed ID: 13871015
    [No Abstract]   [Full Text] [Related]  

  • 13. [First results obtained with the use of the spirolactone SC-9420 (aldactone) in the treatment of ascites caused by liver cirrhosis].
    DE FILIPPIS V; MARSICO F; PEDICINI S
    Riforma Med; 1960 Dec; 74():1516-20. PubMed ID: 13720490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intractractable ascites in alcoholic cirrhosis: treatmemt by punctures and reinjections of ascitic fluid associated with diuretics].
    Perrin D; Bredoux P; Arzul C; Bergerault P; Dedieu P; Miniconi P
    Arch Fr Mal App Dig; 1974; 63(5):365-73. PubMed ID: 4463921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 16. Ascites in cirrhosis: pathophysiology and management.
    Panos M; Williams R
    Br J Hosp Med; 1988 Oct; 40(4):256, 258, 260-2. PubMed ID: 3228657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum potassium patterns in anuria and oliguria.
    HOPPER J; O'CONNELL BP; FLUSS HR
    Ann Intern Med; 1953 May; 38(5):935-54. PubMed ID: 13041036
    [No Abstract]   [Full Text] [Related]  

  • 18. Potassium-chlorate poisoning with oliguria treated by the Bull régime.
    DAVIES P
    Lancet; 1956 May; 270(6923):612-3. PubMed ID: 13320821
    [No Abstract]   [Full Text] [Related]  

  • 19. [Water-electrolyte disorders in hepatic cirrhosis with ascites].
    Arroyo V; Rodes J; Sánchez-Tapias JM; Bordas JM; Teres J; Brugera M; Gassull MA
    Rev Clin Esp; 1972 Mar; 124(5):469-76. PubMed ID: 5034135
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacotherapy of ascites associated with cirrhosis.
    Ginès P; Arrovo V; Rodés J
    Drugs; 1992 Mar; 43(3):316-32. PubMed ID: 1374317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.